Behringer Ingelheim, LLC,   

Fibrinolytic agent - plasminogen activator

Liofilizate for the preparation of a solution for infusions complete with a solvent.

antiviral (HIV) agent
Capsules 250 mg
M-holinoblokator
Suppositories rectal by 10 mg.
Antitumor agent - protein tyrosine kinase inhibitor
Capsules 100, 150 mg.
Antiviral [HIV] agent

Suspension for oral administration 50 mg / 5 ml.

Antiviral [HIV] agent

Tablets 200 mg

Hypoglycemic agent for oral administration combined

Tablets, film-coated, 5 mg 10 mg + 5 mg + 25 mg.

Hypoglycemic agent for oral use of the second-generation sulfonylurea group.
Tablets 30 mg.
Hypoglycemic agent for oral administration

Tablets, film-coated, 10 mg and 25 mg.

A hypoglycemic agent for oral administration combined (dipeptidyl peptidase-4-inhibitor + biguanide)
Tablets, film-coated, 2.5 mg + 500 mg / 2.5 mg + 850 mg / 2.5 mg + 1000 mg.
fibrinolytic agent.

A bottle of colorless glass type I, containing 30 mg (6000 ED), 40 mg (8000 ED), or 50 mg (10,000 units) of lyophilizate for the preparation of a solution for intravenous administration.

The bottle is sealed with a gray bromobutyl stopper, rolled up with an aluminum cap, and a plastic protective cover (gray for 30 mg, yellow-green for 40 mg and red for 50 mg).

In the kit: a plastic syringe with a solvent of 6 ml, or 8 ml, or 10 ml, a disposable needle, adapter.

A bottle, a syringe, an adapter and a needle with instructions for use are placed in a cardboard box.

angiotensin II receptor antagonist.

Tablets of 40 mg and 80 mg.

A combined hypotensive drug (angiotensin II receptor antagonist + diuretic)
Tablets 25/80 mg.
Non-steroidal anti-inflammatory drug - NSAIDs
Suspension for oral administration 7.5 mg / 5 ml.
Non-steroidal anti-inflammatory drug - NSAIDs

Solution for intramuscular injection 15 mg / 1.5 ml.

Non-steroidal anti-inflammatory drug - NSAIDs
Tablets 7.5 mg or 15.0 mg.
Thrombin inhibitor direct

Capsules, 75 mg, 110 mg and 150 mg.

Direct thrombin inhibitor
Capsules 150 mg.

Bronchodilator combined (long-acting β2-adrenomimetic + m-holinoblokator)

Solution for inhalation dosage 2.5 μg + 2.5 μg / dose.

Hypoglycemic agent - dipeptidyl peptidase-4 inhibitor (DPP-4)
Film coated tablets 5 mg.
multivitamin product + other preparations
Capsules.
Non-steroidal anti-inflammatory drug (NSAID)
Gel for external use 0,5%.
local irritant

Ointment for external use.

Local irritant
Cream for external use.